Pharma
NewsBY
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
NewsBY
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
